List view / Grid view
2 April 2015 | By Victoria White
SAGE Therapeutics has announced details of its planned SAGE-547 global Phase 3 development programme for the treatment of patients with SRSE.
2 April 2015 | By Victoria White
pSivida has announced the completion of the targeted enrollment of 120 patients in its pivotal Phase III clinical trial of Medidur for posterior uveitis...
2 April 2015 | By Victoria White
Conatus has announced top-line results from the Phase 2 clinical trial of emricasan, a first-in-class, orally active pan-caspase protease inhibitor...
2 April 2015 | By Victoria White
Proteon has announced positive results from a long-term analysis of follow-up data from a Phase 2 study of its lead candidate, vonapanitase...
2 April 2015 | By Victoria White
Idera has announced that the FDA has granted orphan drug designation for IMO-8400 for the treatment of diffuse large B-cell lymphoma (DLBCL)...
1 April 2015 | By Victoria White
Peregrine has announced promising clinical data from a Phase I trial evaluating bavituximab therapy in patients with metastatic breast cancer...
1 April 2015 | By Victoria White
Three-month paliperidone palmitate significantly delayed time to relapse compared to placebo in patients with schizophrenia, according to a Phase 3 study...
1 April 2015 | By Victoria White
Kala has announced positive results from a Phase 3 clinical trial of KPI-121 for the treatment of patients who have undergone cataract surgery...
1 April 2015 | By Victoria White
InVivo has announced a new clinical site in the ongoing IDE pilot study of its Neuro-Spinal Scaffold in patients with acute spinal cord injury...
1 April 2015 | By Victoria White
"MODHEP: Understanding liver cancer" shown at European Parliament to delegates at an event celebrating collaboration between the EU and other countries...
1 April 2015 | By Victoria White
The US treatment market for Rheumatoid Arthritis is set to increase in value from $6.4 billion in 2013 to $9.3 billion by 2020, says GBI Research...
1 April 2015 | By Victoria White
NeuroDerm has announced that updated results from the Phase II Study of ND0612L will be presented at the American Academy of Neurology 67th Annual Meeting...
1 April 2015 | By Victoria White
BioCryst has announced it has been has awarded a contract for the continued development of BCX4430 as a potential treatment for diseases, including Ebola...
1 April 2015 | By Victoria White
UCB has announced it has entered an agreement with Dr. Reddy’s to sell its established brands in India, allowing it to focus on its neurology portfolio...
31 March 2015 | By Shimadzu
Shimadzu, one of the world leaders in analytical instrumentation, has released the new Nexera UC SFE/SFC/MS platform combining quick and easy on-line sample extraction with state-of-the-art chromatographic separation and high sensitivity detection...
